Skip to main content

Advertisement

Table 7 Economic analysis

From: Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort

Strategy Cost per 100 patients (£)* Cases detected per 100 patients Cost per case detected (£) Incremental cost per 100 patients (with base = E) Incremental cases detected per 100 patients (base = E) ICER
A 5222 1.05 4965 5159 0.61 Dominated**
B 1592 0.70 2270 1530 0.26 Dominated
C 293 0.53 558 231 0.09 (2635)
D 570 0.89 641 508 0.45 1124
E (base)§ 62 0.44 142 0 0.00 Base
F 837 0.96 868 775 0.53 1473
G 4052 1.05 3853 3990 0.61 6503
  1. * Cost of Viral test = £40.52; Cost of LFT Panel = £17.79.
  2. ** Dominated by G.
  3. † Dominated by D and F.
  4. ‡ Strategy C is eliminated by extended dominance.
  5. § Patient born in a country of intermediate to high viral hepatitis prevalence and ALT greater than twice upper limit of normal on primary test is the least expensive strategy and was considered as base case.
  6. ICER: Incremental cost-effectiveness ratio.
  7. LFT: Liver function test.